Loading...
Yooma Wellness Inc.
YOOM.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.005
CA$0.00(0.00%)

The company's financials show resilient growth, with revenue advancing from $5.27M in Q4 2021 to $2.42M in Q3 2022. Gross profit remained healthy with margins at 25% in Q3 2022 compared to 24% in Q4 2021. Operating income hit -$602783.00 last quarter, sustaining a consistent -25% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$600830.00. Net income rose to -$624821.00, while earnings per share reached -$0.006. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan